Showing results (351-360 of 743) with videos related to

Sort By:
Pageof 75
The New England Journal of Medicine|February 22, 2002
A long-term study of prognosis in monoclonal gammopathy of undetermined significanceRobert A Kyle, Terry M Therneau, S Vincent Rajkumar, et al.
Oncotarget|October 24, 2018
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myelomaUtkarsh Painuly, Vijay Ramakrishnan, Teresa Kimlinger, et al.
Haematologica|March 1, 2024
Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasoneKarthik Ramasamy, Nizar J Bahlis, Shaji K Kumar, et al.
Blood|November 15, 2014
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myelomaShaji K Kumar, Betsy LaPlant, Wee Joo Chng, et al.
Scientific Reports|June 26, 2020
Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple MyelomaWilson I Gonsalves, Katarzyna Broniowska, Erik Jessen, et al.
Blood Cancer Journal|May 19, 2019
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathiesShaji Kumar, Dirk R Larson, Angela Dispenzieri, et al.
Clinical Chemistry|June 13, 2009
Screening panels for detection of monoclonal gammopathiesJerry A Katzmann, Robert A Kyle, Joanne Benson, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemiaRobert A Kyle, Terry M Therneau, Angela Dispenzieri, et al.
Cancer|October 10, 2013
Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategiesBrian L Burnette, Angela Dispenzieri, Shaji Kumar, et al.
Blood|July 31, 2009
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myelomaCheng E Chee, Shaji Kumar, Dirk R Larson, et al.
Pageof 75